Abstract:Preclinical and clinical investigations have identified unresolved inflammation and oxidative/nitrosative stress as two coconspirators, which play a multifaceted role and serve as driving force in the journey to cancer development. Ulcerative colitis is an inflammatory disease of the colon that predisposes to colorectal cancer, the fourth leading cause of cancer worldwide. Overexpression of proinflammatory mediators, a distinct network of intracellular signaling molecules including upstream kinases and transcription factors, facilitates tumor promotion and CRC progression. Current therapeutic drugs for CRC have severe adverse effects. Several investigations indicate that a plant-based diet rich in a wide variety of fruits and vegetables is effective in preventing or reversing premalignant lesions. Thus, the search for novel chemopreventive agents of physiologic relevance acting on specific and/or multiple molecular and cellular targets holds promise as a rational strategy for the control of health-threatening diseases such as ulcerative colitis and CRC. A bioactive component, 6-gingerol from ginger (Zingiber officinale) has been reported to possess antioxidant and anti-inflammatory activities. Our study demonstrates that 6-gingerol protects against dextran sulfate sodium (DSS)-induced ulcerative colitis in BalBc mice. 6-Gingerol attenuated DSS-mediated increase in immunoexpression of nuclear factor kappa B (NF-κB [p65]), tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1 β), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), mitogen-activated kinase (P 38), RANTES, Bcl2, monocyte chemoattractant protein (MCP-1), and β-catenin expression. Similarly, 6-gingerol modulated DSS decrease in adenomatous polyposis coli (APC), DESMIN, Interleukin 10, and levels of antioxidant enzymes. In the two-stage (DMBA initiation and TPA promotion) mouse skin carcinogenesis model, 6-gingerol downregulated the expression of COX-2 and NF-κB. Also, in the benzo(a)pyrene and DSS (BDS) model of colorectal cancer, BDS induced adenocarcinoma and decreased APC, p53 expression, and number of apoptotic cells. In addition, tumor incidence, β-catenin, and cyclin D1 expressions were increased. Treatment with 6-gingerol decreased adenocarcinoma significantly and modulated the expression of these proteins and transcription factors. This anti-inflammatory phytochemical exerted chemopreventive effects by modulating intracellular signaling cascades and proinflammatory mediators and therefore qualifies as therapeutic signature for chemoprevention of inflammation-associated CRC. Citation Format: Ebenezer O. Farombi, Babajide O. Ajayi, Isaac A. Adedara, Solomon E. Owumi. 6-Gingerol, a chemopreventive phytochemical as speed breaker in inflammatory and stress signaling cascade triggered by benzo(a)pyrene and dextran sulphate sodium-mediated colorectal cancer in mice [abstract]. In: Proceedings of the AACR Special Conference on Environmental Carcinogenesis: Potential Pathway to Cancer Prevention; 2019 Jun 22-24; Charlotte, NC. Philadelphia (PA): AACR; Can Prev Res 2020;13(7 Suppl): nr A39.

Mechanistic exploration of 6-shogaol's preventive effects on azoxymethane and dextran sulfate sodium -induced colorectal cancer: involvement of cell proliferation, apoptosis, carcinoembryonic antigen, wingless-related integration site signaling, and oxido-inflammation

Abstract A39: 6-Gingerol, a chemopreventive phytochemical as speed breaker in inflammatory and stress signaling cascade triggered by benzo(a)pyrene and dextran sulphate sodium-mediated colorectal cancer in mice

6-Shogaol Inhibits the Cell Migration of Colon Cancer by Suppressing the EMT Process Through the IKKβ/NF-κB/Snail Pathway

Review of the anticancer properties of 6-shogaol: Mechanisms of action in cancer cells and future research opportunities

Protective effect of Shaoyao Decoction against colorectal cancer via the Keap1-Nrf2-ARE signaling pathway

6-Shogaol Derived from Ginger Inhibits Intestinal Crypt Stem Cell Differentiation and Contributes to Irritable Bowel Syndrome Risk

6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway

Anti-inflammatory effect and signaling mechanism of 8-shogaol and 10-shogaol in a dextran sodium sulfate-induced colitis mouse model

6-Shogaol improves sorafenib efficacy in colorectal cancer cells by modulating its cellular accumulation and metabolism

6-Shogaol Ameliorates Liver Inflammation and Fibrosis in Mice on a Methionine- and Choline-Deficient Diet by Inhibiting Oxidative Stress, Cell Death, and Endoplasmic Reticulum Stress

EGCG and Polyphenon E attenuate inflammation-related mouse colon carcinogenesis induced by AOM plus DDS

Differentially Expressed Genes (DEGs) Analysis Indicating 6-Shogaol Anticancer Activity Against HCT-116 Cells Performed Primarily by Affecting Genes in Common (SHARED-DEGs) of Apoptotic and P53 Signaling Pathways

Transcriptome and proteomics conjoint analysis reveal metastasis inhibitory effect of 6-shogaol as ferroptosis activator through the PI3K/AKT pathway in human endometrial carcinoma in vitro and in vivo

6-Shogaol from Dried Ginger Protects against Intestinal Ischemia/Reperfusion by Inhibiting Cell Apoptosis via the BDNF/TrkB/PI3K/AKT Pathway

Chemopreventive Effects of Polysaccharides and Flavonoids from Okra Flowers in Azomethane/Dextran Sulfate Sodium-Induced Murine Colitis-Associated Cancer

Inhibitory Effect of a Microecological Preparation on Azoxymethane/Dextran Sodium Sulfate-Induced Inflammatory Colorectal Cancer in Mice

ShaoYao decoction ameliorates colitis-associated colorectal cancer by downregulating proinflammatory cytokines and promoting epithelial-mesenchymal transition

Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota

Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota

Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer